≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Epileptic seizures related to drugs

Endpoint Browser PheWeb

EPILEPTIC_SEIZU_RELATED_DRUGS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G40.52#

1 out of 7 registries used, show all original rules.

109

4. Check minimum number of events

None

109

5. Include endpoints

None

109

6. Filter based on genotype QC (FinnGen only)

109

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 693 270 422
Only index persons 667 264 403
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.02
Median age at first event (years)
Whole population 34.78 37.41 33.12
Only index persons 34.73 37.19 33.12

-FinnGen-

Key figures

All Female Male
Number of individuals 109 50 59
Unadjusted period prevalence (%) 0.02 0.02 0.03
Median age at first event (years) 39.61 42.00 37.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
105
Matched controls
1051
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
+∞
151.4
105
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
78.0
59.4
66
22
N05AH02
ATC
clozapine; systemic
71.4
58.3
66
24
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
44.2
57.5
79
67
N03AG01
ATC
valproic acid; systemic, rectal
35.4
46.9
64
44
N05AH03
ATC
olanzapine; systemic
24.6
40.5
63
60
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
41.3
37.6
47
20
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
35.9
36.1
47
23
N05AX08
ATC
risperidone; systemic
20.6
33.6
54
51
N03AX09
ATC
lamotrigine; oral
29.3
32.1
44
25
F29
ICD-10 Finland
Unspecified nonorganic psychosis
21.2
31.9
50
43
N05AH04
ATC
quetiapine; oral
13.3
31.2
70
137
N05BA01
ATC
diazepam; systemic, rectal
16.2
30.1
54
64
F20.9
ICD-10 Finland
Schizophrenia, unspecified
29.9
29.5
40
21
N05BA06
ATC
lorazepam; systemic, sublingual
27.4
28.1
39
22
N05AA02
ATC
levomepromazine; systemic
21.8
27.8
42
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
20.6
27.7
43
34
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
41.1
27.6
34
12
G40.9
ICD-10 Finland
Epilepsy, unspecified
32.8
26.0
34
15
N05AX12
ATC
aripiprazole; systemic
15.3
24.9
44
47
N04AA02
ATC
biperiden; systemic
41.2
24.4
30
10
AA1AD
NOMESCO Finland
CT of head and brain
9.7
23.0
56
110
N05BA04
ATC
oxazepam; oral
8.8
22.6
62
147
N05CD07
ATC
temazepam; oral
14.1
21.7
39
42
N05AF03
ATC
chlorprothixene; systemic
21.4
20.9
31
20
N05AB03
ATC
perphenazine; systemic, rectal
22.8
20.7
30
18
P72
ICPC
Schizophrenia
21.7
19.8
29
18
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
14.2
17.8
31
30
N03AE01
ATC
clonazepam; systemic
14.8
16.5
28
25
N06AB04
ATC
citalopram; systemic
6.6
16.3
51
131
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
14.2
16.2
28
26
C07AA05
ATC
propranolol; systemic
6.4
15.3
48
122
N06AB06
ATC
sertraline; oral
7.7
15.2
39
75
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
10.3
15.1
31
41
N05AD01
ATC
haloperidol; systemic
27.0
14.9
20
9
N06AX11
ATC
mirtazapine; oral
5.5
14.8
59
198
N05CF01
ATC
zopiclone; oral
5.5
14.4
54
168
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
159.8
13.8
14
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.9
13.6
28
37
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
57.7
13.2
15
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
8.3
12.2
28
44
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
22.2
12.0
17
9
N05AF05
ATC
zuclopenthixol; systemic
34.6
12.0
15
5
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
26.6
12.0
16
7
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
26.6
12.0
16
7
N05AA01
ATC
chlorpromazine; systemic, rectal
26.6
12.0
16
7
P29
ICPC
Psychological sympt/compl other
9.7
11.7
24
31
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.0
11.7
17
10
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
28.8
11.5
15
6
N05BA12
ATC
alprazolam; oral
7.0
11.2
29
54
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
6.2
11.1
32
69
N06AX16
ATC
venlafaxine; oral
5.4
11.0
37
96
C07AB07
ATC
bisoprolol; oral
4.2
10.6
52
197
G40
ICD-10 Finland
Epilepsy
121.7
10.6
11
*
F20
ICD-10 Finland
Schizophrenia
36.7
10.6
13
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
+∞
10.6
10
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
13.3
10.5
18
16
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.8
10.3
31
70
N03AF02
ATC
oxcarbazepine; oral
15.5
10.1
16
12
EBA00
NOMESCO Finland
Extraction of tooth
3.9
9.9
57
243
A06AD11
ATC
lactulose; oral
7.0
9.9
25
45
R42
ICD-10 Finland
Dizziness and giddiness
4.9
9.7
35
97
N05BE01
ATC
buspirone; oral
12.4
9.7
17
16
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.6
9.7
30
70
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
33.5
9.6
12
*
N07BB01
ATC
disulfiram; oral
8.5
9.6
21
30
AA400
NOMESCO Finland
Electroconvulsive therapy
24.4
9.6
13
6
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.6
9.3
36
107
F10.24
ICD-10 Finland
Alcohol depence active use
40.5
9.2
11
*
N06AB03
ATC
fluoxetine; oral
5.4
9.2
29
69
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.5
9.1
28
65
K59.09
ICD-10 Finland
Constipation, unspecified
11.6
8.9
16
16
K08.3
ICD-10 Finland
Retained dental root
7.4
8.9
21
34
R25.1
ICD-10 Finland
Tremor, unspecified
18.3
8.8
13
8
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
30.4
8.7
11
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
12.3
8.6
15
14
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
9.4
8.5
17
21
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
9.4
8.5
17
21
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
13.2
8.4
14
12
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
19.1
8.3
12
7
183
Kela drug reimbursment
Lamotrigin and topiramate
36.5
8.2
10
*
N05AN01
ATC
lithium; oral
10.7
8.1
15
16
188
Kela drug reimbursment
Psychosis requiring demanding treatment
12.2
8.1
14
13
N05AE03
ATC
sertindole; oral
48.8
7.8
9
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
48.8
7.8
9
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
11.3
7.8
14
14
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
11.3
7.8
14
14
SFA10
NOMESCO Finland
Fillning on one surface of tooth
3.4
7.8
76
457
SPAT1240
SPAT
Therapeutic discussion
4.4
7.7
30
88
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.8
7.7
19
33
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
7.6
53
250
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
12.2
7.5
13
12
EBA05
NOMESCO Finland
Complicated extraction of tooth
3.8
7.5
35
121
P99
ICPC
Psychological disorders other
8.4
7.5
16
22
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.1
7.4
20
39
F10.20
ICD-10 Finland
Alcohol dependence currently independent
17.3
7.4
11
7
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
9.9
7.3
14
16
N05CF02
ATC
zolpidem; oral
3.9
7.3
33
111
N05AC02
ATC
thioridazine; oral
13.4
7.3
12
10
G72.8
ICD-10 Finland
Other specified myopathies
21.9
7.3
10
5
K02.1
ICD-10 Finland
Caries of dentine
3.5
7.3
82
533
A28
ICPC
Limited function/disability NOS
5.6
7.2
21
45
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.6
7.2
18
32
N06AA12
ATC
doxepin; systemic
7.7
7.1
16
24
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
15.2
7.1
11
8
F20.0
ICD-10 Finland
Paranoid schizophrenia
15.2
7.1
11
8
P15
ICPC
Chronic alcohol abuse
10.4
7.0
13
14
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.4
7.0
18
33
N05AL01
ATC
sulpiride; systemic
18.2
6.9
10
6
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
3.0
6.8
56
289
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
24.4
6.8
9
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
24.4
6.8
9
*
SPAT1243
SPAT
Psychiatric/psychological examination
9.7
6.8
13
15
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.1
6.7
12
12
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
15.6
6.5
10
7
N88
ICPC
Epilepsy
74.2
6.5
7
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
74.2
6.5
7
*
N03AX14
ATC
levetiracetam; systemic
10.2
6.5
12
13
N03AF01
ATC
carbamazepine; oral, rectal
7.9
6.5
14
20
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.2
6.4
25
73
P98
ICPC
Psychosis NOS/other
19.5
6.4
9
5
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
8.6
6.3
13
17
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
28.6
6.3
8
*
RT250
NOMESCO Finland
NA
+∞
6.3
6
*
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
+∞
6.3
6
*
N05BA09
ATC
clobazam; oral
+∞
6.3
6
*
F20.5
ICD-10 Finland
Residual schizophrenia
+∞
6.3
6
*
P19
ICPC
Drug abuse
13.6
6.2
10
8
R41.0
ICD-10 Finland
Disorientation, unspecified
13.6
6.2
10
8
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
11.0
6.2
11
11
N06AX12
ATC
bupropion; oral
5.0
6.1
19
44
K04.5
ICD-10 Finland
Chronic apical periodontitis
3.2
6.1
36
147
F10.25
ICD-10 Finland
Alcohol dependence continuous use
16.2
6.0
9
6
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
16.2
6.0
9
6
N03AX16
ATC
pregabalin; oral
3.2
6.0
35
140

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
35
34
14.69
33.38
10.5
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
61
8.67
23.33
10.2
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
82
300
8.00
23.19
7.0
7.5
mmol/l
1.2
1.2
2.62
74
280
(3016879) Cocaine [Presence] in Urine
38
76
7.14
19.83
10.9
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
93
433
8.82
18.83
23.8
6.9
e9/l
0.2
0.2
1.30
83
387
(3001604) Monocytes [#/volume] in Blood
91
418
8.13
18.60
19.3
6.4
e9/l
0.6
0.6
0.30
79
374
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
81
336
6.49
18.58
8.0
8.7
mmol/l
1.2
1.2
1.03
70
294
(3000764) Benzodiazepines [Presence] in Urine
38
81
6.67
18.51
10.9
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
81
6.67
18.51
10.9
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
81
6.67
18.51
11.0
1.4
—
—
—
0
0
(3012544) pH of Venous blood
34
65
7.15
18.42
3.6
4.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
91
421
8.03
18.36
19.6
6.4
e9/l
0.0
0.0
0.10
79
375
(3027944) Amphetamines [Presence] in Urine
37
81
6.40
17.45
10.3
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
91
434
7.64
17.33
20.5
6.4
e9/l
2.0
1.9
0.61
79
391
(3002032) Base excess in Venous blood by calculation
33
65
6.85
17.29
4.3
3.7
mmol/l
2.9
2.4
0.21
28
49
(3011288) Drugs identified in Urine by Screen method
30
55
7.15
16.81
19.5
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
90
5.95
16.40
1.7
1.6
nmol/l
1435.9
1275.0
0.31
33
71
(3000991) Gas panel - Venous blood
31
61
6.70
16.18
4.4
9.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
72
299
5.15
15.65
4.8
5.1
g/l
34.8
37.3
2.44
66
287
(40758558) Short blood count panel - Blood
57
200
4.88
15.30
31.5
7.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
35
8.06
15.14
1.5
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
54
183
4.87
15.12
5.2
4.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
36
87
5.69
15.09
2.1
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
84
5.66
14.75
1.9
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
64
257
4.61
14.16
3.7
2.9
u/l
43.5
55.3
3.46
58
242
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
23
38
7.40
14.04
6.3
14.3
%
0.8
0.7
0.16
23
38
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
124
4.88
13.80
2.1
1.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
23
39
7.21
13.70
6.3
14.0
%
2.0
1.9
0.10
23
39
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
244
4.41
13.39
2.9
3.5
mmol/l
2.3
2.3
0.65
52
220
(3018418) pH of Serum or Plasma
54
198
4.42
13.34
3.7
3.7
ph
7.4
7.4
—
7
38
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
61
246
4.36
13.20
2.3
1.7
pmol/l
100.2
93.0
0.80
40
123
(3018405) Lactate [Moles/volume] in Arterial blood
18
24
8.79
13.11
6.7
7.0
mmol/l
1.2
1.2
0.09
18
24
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
5
34.36
12.00
1.7
1.6
umol/l
15.4
18.2
—
15
5
(3019060) Gas panel - Arterial blood
21
37
6.79
12.00
6.9
17.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
21
38
6.61
11.68
6.8
14.5
%
91.5
93.1
0.36
21
38
(3026008) Bacteria identified in Urine by Culture
50
191
3.99
11.33
3.2
2.5
—
—
—
0
0
(4198724)
16
9
20.55
11.11
3.6
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
78
407
4.22
11.10
7.2
6.6
umol/l
7.8
10.5
3.92
73
388
(42870588) Differential panel, method unspecified - Blood
57
249
3.70
10.41
9.3
5.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
64
314
3.51
9.53
2.5
2.5
nmol/l
65.0
74.8
1.92
58
285
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
34
111
4.00
9.41
2.2
2.8
mmol/l
2.4
2.4
0.27
26
102
(3020891) Body temperature
17
31
6.31
9.30
10.3
4.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
9
16.17
8.44
2.2
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
92
630
3.95
6.96
5.7
4.0
pmol/l
14.3
14.6
0.71
86
586
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
53
268
2.90
6.91
3.9
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
14
7.76
6.82
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
14
7.76
6.82
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
46
218
2.92
6.73
16.5
4.8
—
—
—
0
0
(3015736) pH of Urine
59
324
2.79
6.47
7.3
2.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
100
773
4.55
6.37
7.3
4.5
mu/l
1.9
1.8
0.27
92
723
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
92
3.40
6.20
16.5
6.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
266
2.72
6.10
5.4
3.1
ng/l
54.3
23.5
0.49
39
156
(3007853) Bacteria identified in Skin by Aerobe culture
27
99
3.30
6.08
1.7
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
81
540
2.95
5.87
5.2
3.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
379
0.25
5.67
5.9
2.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
64
389
2.56
5.42
19.9
8.6
e9/l
0.0
0.0
0.49
50
314
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
5
0
+∞
5.24
2.4
0.0
ug/l
2.6
—
—
5
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
166
2.63
4.89
2.1
1.8
mg/l
1.0
0.9
0.11
28
126
(3013707) Erythrocyte sedimentation rate by Westergren method
84
599
2.75
4.85
3.9
3.6
mm/h
10.3
8.3
0.51
76
562
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
54
3.55
4.72
1.4
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
41
3.77
4.35
2.1
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
42
229
2.36
4.29
4.1
2.6
e6/l
28.7
11.8
0.59
32
181
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
32
4.09
4.21
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
137
2.52
4.02
2.8
2.1
e6/l
0.6
0.8
0.22
15
72
(3012516) Albumin [Mass/volume] in Urine
34
174
2.39
3.96
2.7
3.5
mg/l
84.1
37.3
0.41
22
119
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
90
699
2.65
3.78
7.8
2.9
u/l
51.0
40.5
0.93
85
672
(3030467) Casts [#/volume] in Urine by Automated count
39
217
2.24
3.72
3.6
2.5
e6/l
0.1
0.3
0.91
30
162
(3018095) Leukocytes [#/volume] in Urine
46
276
2.15
3.63
5.1
3.1
e6/l
122.9
26.1
0.72
35
193
(3023511) Choriogonadotropin [Units/volume] in Urine
10
27
3.98
3.44
2.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
10
7.39
3.42
1.1
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
42
249
2.12
3.37
13.7
7.2
inr
1.1
1.2
0.07
12
74
(36304419) Bacteria [Presence] in Urine
38
217
2.15
3.36
3.6
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
99
824
3.20
3.30
6.7
3.5
mmol/l
6.3
5.7
2.67
92
768
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
7
8.98
3.30
1.2
1.0
miu/ml
1122.7
1826.1
—
6
7
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
103
899
3.64
3.22
29.7
11.8
mg/l
21.9
20.9
0.16
95
678
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
190
2.15
3.15
6.5
3.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
8
7.85
3.09
5.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
28
148
2.20
2.96
3.1
3.3
ng/l
656.6
662.5
0.01
21
119
(3052851) Hemolysis interference index of Serum or Plasma
9
22
4.36
2.95
4.8
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
13
5.67
2.92
2.4
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
24
120
2.28
2.89
2.6
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
32
182
2.07
2.80
4.0
4.3
mg/mmol
17.7
5.8
0.57
24
124
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
14
5.26
2.77
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
15
4.91
2.64
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
121
2.14
2.44
3.5
2.2
e6/l
1.7
3.3
—
10
57
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
8
6.48
2.39
6.6
3.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
29
3.29
2.28
1.2
1.2
—
—
—
0
0
(44790049)
5
9
5.76
2.23
1.4
1.4
—
—
—
0
0
(44790047)
5
9
5.76
2.23
1.4
1.4
—
—
—
0
0
(44806118)
5
9
5.76
2.23
1.4
1.4
—
—
—
0
0
(44790048)
5
9
5.76
2.23
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
24
133
2.03
2.22
4.3
3.1
ng/l
13.3
119.0
1.36
17
86
(3013512) EKG study
32
199
1.86
2.13
7.6
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
20
3.67
2.09
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
71
2.29
2.03
4.9
3.0
—
—
—
0
0
(3036489) Thrombin time
9
33
2.88
1.98
1.2
2.3
s
19.6
22.8
—
9
28
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
27
3.11
1.98
5.5
34.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
11
4.71
1.96
4.6
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
34
222
1.77
1.91
7.5
3.1
estimate
0.0
0.0
—
5
81
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
66
2.29
1.91
3.5
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
17
3.67
1.86
6.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
14
67
2.25
1.85
2.4
5.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.31
1.84
1.8
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
15
75
2.16
1.80
9.3
5.1
%
0.9
0.9
—
7
21
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
218
0.45
1.76
2.2
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
96
849
2.10
1.74
21.7
10.2
ml/min/173m2
97.2
92.9
1.05
74
682
(3037467) Urinalysis macro (dipstick) panel - Urine
70
567
1.66
1.71
5.1
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
55
420
1.62
1.70
6.0
3.0
estimate
0.0
0.0
—
7
85
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
19
3.28
1.68
1.2
1.1
—
—
—
0
0
(4306422)
5
14
3.69
1.63
1.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
26
2.80
1.61
1.0
2.4
%
166.4
177.5
—
7
26
(3000494) Fungus identified in Specimen by Culture
18
102
1.92
1.56
1.7
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
27
2.70
1.54
1.3
2.3
%
89.4
96.3
—
7
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
15
3.44
1.54
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
21
2.96
1.53
1.0
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
55
428
1.58
1.52
6.2
3.0
estimate
0.0
0.0
—
6
79
(3036481) Cortisol [Moles/volume] in Serum or Plasma
14
73
2.05
1.52
1.6
2.0
nmol/l
346.7
400.8
0.46
14
66
(3019832) Treponema pallidum Ab [Presence] in Serum
7
147
0.44
1.45
2.0
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
204
0.49
1.45
2.2
2.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
22
2.82
1.45
1.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
24
2.58
1.32
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
24
2.58
1.32
1.3
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
53
419
1.52
1.31
7.2
4.2
estimate
0.0
0.0
—
7
84
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
18
2.86
1.30
1.4
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.86
1.30
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
13
71
1.94
1.25
10.5
5.2
%
0.0
0.2
—
5
18
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
19
2.71
1.23
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
38
2.19
1.21
1.4
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
26
2.38
1.20
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
34
0.00
1.18
0.0
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
30
214
1.55
1.17
1.3
1.3
u/ml
2.0
2.0
0.01
12
61
(3000330) Specific gravity of Urine by Test strip
7
33
2.20
1.07
3.3
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
22
2.33
1.04
1.4
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
29
0.00
0.99
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
29
0.00
0.99
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
29
0.00
0.99
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
29
0.00
0.99
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
28
0.00
0.99
0.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
765
0.70
0.94
3.8
3.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
97
901
1.70
0.92
6.0
3.8
mmol/l
2.7
2.9
1.12
88
851
(4034850)
6
29
2.13
0.91
35.5
9.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
22
156
1.51
0.88
2.9
3.7
%
18.5
23.4
—
7
58
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
146
0.58
0.86
1.1
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
31
1.99
0.86
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
96
894
1.62
0.84
5.5
3.6
mmol/l
1.2
1.4
5.08
90
843
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
43
351
1.37
0.82
5.5
4.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
91
1.62
0.80
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
96
897
1.59
0.79
5.7
3.6
mmol/l
4.5
4.8
1.69
90
846
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
41
334
1.36
0.78
6.7
2.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
23
2.23
0.77
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
26
1.97
0.71
1.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
93
868
1.49
0.71
5.1
3.3
mmol/l
1.6
1.3
2.15
87
813
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
173
1.42
0.69
2.1
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
73
1.56
0.59
1.8
2.4
—
32.1
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
27
215
1.34
0.58
2.5
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
29
234
1.33
0.58
2.4
2.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
82
1.52
0.57
2.2
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
38
1.61
0.55
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
83
1.50
0.54
2.1
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
40
1.53
0.52
1.2
1.8
mg/l
7.4
2.4
—
6
27
(3000492) Spirometry study
7
108
0.62
0.51
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
48
1.49
0.48
5.6
2.0
—
—
—
0
0
(4010399)
7
48
1.49
0.48
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
100
961
1.49
0.46
28.4
9.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
104
1.40
0.46
1.6
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
96
1.40
0.44
2.3
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
29
243
1.26
0.44
1.2
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
57
1.43
0.43
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
33
1.54
0.42
2.4
2.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
2.9
—
0
5
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
4.3
—
0
7
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
2.2
—
0
6
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
36
1.41
0.38
3.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
144
0.74
0.36
1.6
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
23
192
1.25
0.36
1.3
1.5
g/l
2.3
2.2
0.11
14
123
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
20
167
1.24
0.31
3.5
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
272
1.20
0.31
2.9
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
244
0.83
0.28
5.0
2.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
41
1.23
0.22
1.0
1.7
u/l
35.4
42.0
—
5
34
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
1.7
—
13.3
—
0
11
(3045424) Erythrocytes [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
10
0.00
0.21
0.0
1.2
—
35.1
—
0
10
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
10
0.00
0.21
0.0
2.0
—
0.1
—
0
10
(3011412) CD3 cells [#/volume] in Blood
0
12
0.00
0.21
0.0
2.2
—
1.2
—
0
5
(3023420) DNA double strand Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
81
1.26
0.19
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
65
0.76
0.17
1.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
71
0.84
0.08
8.5
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
84
1.08
0.07
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
30
314
0.94
0.06
1.9
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
220
1.06
0.04
1.6
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
89
882
1.05
0.02
51.2
11.9
%
40.1
41.7
0.81
50
733
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
140.3
—
0
9
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
9
0.00
0.00
0.0
1.7
—
0.2
—
0
9
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
6
0.00
0.00
0.0
3.0
—
74.0
—
0
6
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
31.7
—
0
5
(3021788) Differential panel - Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
6.0
—
172.5
—
0
6
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
54
0.92
0.00
1.4
3.9
ug/l
2.7
6.9
—
5
44
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
11.0
—
0
6
(4146454)
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
53
0.94
0.00
2.2
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.2
—
0
7
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.4
—
74.6
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
6.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
8
86
0.92
0.00
1.5
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.3
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
40.9
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
6.0
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint EPILEPTIC_SEIZU_RELATED_DRUGS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
EPILEPTIC_SEIZU_RELATED_DRUGS 5.024 [2.97, 8.51] < 0.001
Birth year 0.988 [0.98, 1.0] 0.013

During the follow-up period (1.1.1998 — 31.12.2019), 62 out of 360 males with EPILEPTIC_SEIZU_RELATED_DRUGS died.

Mortality risk

Mortality risk for people of age

years, who have EPILEPTIC_SEIZU_RELATED_DRUGS.

N-year risk Females Males
1 No data 1.073%
5 No data 6.186%
10 No data 14.248%
15 No data 25.592%
20 No data 40.267%

Relationships between endpoints

↥

Index endpoint: EPILEPTIC_SEIZU_RELATED_DRUGS – Epileptic seizures related to drugs

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data